AAAAAA

   
Results: 1-8 |
Results: 8

Authors: BREWSTER DH BAIN MRS CHALMERS JWT GOULD A DEWAR JA GEORGE WD
Citation: Dh. Brewster et al., INFORMED CONSENT - EXPLICIT CONSENT IS NOT NEEDED FOR STUDIES USING MEDICAL RECORDS, BMJ. British medical journal, 317(7163), 1998, pp. 948-948

Authors: TWELVES CJ THOMSON CS GOULD A DEWAR JA
Citation: Cj. Twelves et al., VARIATION IN THE SURVIVAL OF WOMEN WITH BREAST-CANCER IN SCOTLAND, British Journal of Cancer, 78(5), 1998, pp. 566-571

Authors: DEWAR JA STEWART HJ MACDONALD TM
Citation: Ja. Dewar et al., TAMOXIFEN COMPLIANCE IN A CLINICAL-TRIAL, Breast, 5(3), 1996, pp. 152-153

Authors: BREWSTER D EVERINGTON D GOULD A HARKNESS E WARNER J DEWAR JA ARRUNDALE J
Citation: D. Brewster et al., INCIDENCE OF AND MORTALITY FROM BREAST-CANCER SINCE INTRODUCTION OF SCREENING - SCOTTISH FIGURES SHOW HIGHER INCIDENCE AND SIMILAR MORTALITY, BMJ. British medical journal, 312(7031), 1996, pp. 639-640

Authors: CREE IA KURBACHER CM UNTCH M SUTHERLAND LA HUNTER EM SUBEDI AMC JAMES EA DEWAR JA PREECE PE ANDREOTTI PE BRUCKNER HW
Citation: Ia. Cree et al., CORRELATION OF THE CLINICAL-RESPONSE TO CHEMOTHERAPY IN BREAST-CANCERWITH EX-VIVO CHEMOSENSITIVITY, Anti-cancer drugs, 7(6), 1996, pp. 630-635

Authors: STEWART HJ FORREST AP EVERINGTON D MCDONALD CC DEWAR JA HAWKINS RA PRESCOTT RJ GEORGE WD
Citation: Hj. Stewart et al., RANDOMIZED COMPARISON OF 5 YEARS OF ADJUVANT TAMOXIFEN WITH CONTINUOUS THERAPY FOR OPERABLE BREAST-CANCER, British Journal of Cancer, 74(2), 1996, pp. 297-299

Authors: DEWAR JA ARRIAGADA R BENHAMOU S BENHAMOU E BRETEL JJ PELLAECOSSET B MARIN JL PETIT JY CONTESSO G SARRAZIN D
Citation: Ja. Dewar et al., LOCAL RELAPSE AND CONTRALATERAL TUMOR RATES IN PATIENTS WITH BREAST-CANCER TREATED WITH CONSERVATIVE SURGERY AND RADIOTHERAPY (INSTITUT-GUSTAVE-ROUSSY 1970-1982), Cancer, 76(11), 1995, pp. 2260-2265

Authors: KNAPP MJ KNOPMAN DS SOLOMON PR PENDLEBURY WW DAVIS CS GRACON SI APTER JT LAZARUS CN BAKER KE BARNETT M BAUMEL B EISNER LS CASTELLS B BOLOURI R BENNETT D FORCHETTI C LEVIN A BLASS JP NOLAN KA GAINES ER RELKIN N BORISON RL DIAMOND B CELESIA GG ROSS AP DEXTER J DOODY R LIPSCOMB L KREITER K DUBOFF EA BLOCK P MARSHALL D WESTERGAARD N EARL NL WYNE SV HINMANSMITH E FARLOW M HENDRIE HC CARESS JA FARMER M HARPER JE FERGUSON J FOSTER NL BARBAS NR BLUEMLEIN LA GELB DJ BERENT S GIORDANI B GREENWALD M BERGMAN S ROGER LF GROENENDYK A WOOD M JURKOWSKI C KATZ I DOYLE S SMITH BD KELLNER C BERNSTEIN HJ BACHMAN DL KNOPMAN DS DEINARD S LANGLEY L BRIDGES S MARGOLIN RA BURGER MC WISER SL CRENSHAW C MORRIS JC RUBIN EH COATS MA REYES PF BENTZ C DOYLE LL RYMER MM BETTINGER IE LAUBINGER MP SADOWSKY CH MARTINEZ W ZUNIGA J STONE R WINNER P MATE L LESSARD C SCHNEIDER L PAWLUCZYK S SMITH WT LOSK SN MARAMBE L SOLOMON PR PENDLEBURY WW GROCCIAELLISON ME EDWARDS KR TAYLOR J CALABRESE VP HARKINS SW THEIN SG DEWAR JA WILLIAMS G DRENNAN C TUTTLE P PRINCIPI N FORD EM TYNDALL RJ KELLEY CK
Citation: Mj. Knapp et al., A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE, JAMA, the journal of the American Medical Association, 271(13), 1994, pp. 985-991
Risultati: 1-8 |